Table 4 Descriptive statistics for antibiotic associated disability cases
From: Evaluation of disability in patients exposed to fluoroquinolones
FQ AD | AZ/ST AD | ||||
|---|---|---|---|---|---|
N = 264 | N = 243 | ||||
Count | % | Count | % | ||
Age | Mean (sd) | 48.5 (8.2) | 48.8 (8.7) | ||
Median | 49 | 51 | |||
Range | 26–64 | 24–64 | |||
18–29 years | 5 | 1.9 | 6 | 2.5 | |
30–59 years | 238 | 90.2 | 218 | 89.7 | |
> = 60 years | 21 | 8.0 | 19 | 7.8 | |
Gender | Female | 146 | 55.3 | 152 | 62.6 |
Male | 118 | 44.7 | 91 | 37.4 | |
Non-UTI Casesa | Total | 164 | 62.1 | 207 | 85.2 |
Female | 73 | 44.5 | 122 | 58.9 | |
Male | 91 | 55.5 | 85 | 41.1 | |
Indication | Sinusitis | 97 | 33.1 | 96 | 35.3 |
Bronchitis | 50 | 17.1 | 100 | 36.8 | |
Cystitis/UTI | 100 | 34.1 | 36 | 13.2 | |
Sinusitis/bronchitis | 15 | 5.1 | 9 | 3.3 | |
Bronchitis/UTI | 2 | 0.7 | 2 | 0.7 | |
Days to AE Onset | Mean (sd) | 9.7 (7.1) | 10.5 (7.8) | ||
Median | 8 | 8 | |||
Range | 1–30 | 1–29 | |||
1–2 days | 41 | 15.5 | 38 | 15.6 | |
3–4 days | 33 | 12.5 | 29 | 11.9 | |
5–10 days | 88 | 33.3 | 77 | 31.7 | |
> 10 days | 102 | 38.6 | 99 | 40.7 | |
Days to Confirmatory Diagnosis | Mean (sd) | 46.7 (16.0) | 49.0 (16.0) | ||
Range 30–90 days | Median | 42 | 44 | ||